Cardio Diagnostics Quote - CDIO

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.4802

Bid

0.4802

Offer

0.50

Volume

1,186,837

0.4502 Day's Range 0.5242

0.19 52 Week Range 1.86

Market Cap

19.419M

Previous Close

0.50

Open

0.519

Last Trade

2000

0.4802

(formt)

Last Trade Time

Financial Volume

US$ 570,614

VWAP

0.480785

Average Volume (3m)

6,738,751

Shares Outstanding

40,439,810

Dividend Yield

PE Ratio

-2.37

Earnings Per Share (EPS)

-0.21

Revenue

17k

Net Profit

-8.38M

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenet... Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease. Show more

Sector

Blank Checks

Industry

In Vitro,in Vivo Diagnostics

Headquarters

Dover, Delaware, USA

Founded

2021

Cardio Diagnostics Holdings Inc is listed in the Blank Checks sector of the NASDAQ with ticker CDIO. The last closing price for Cardio Diagnostics was US$0.50. Over the last year, Cardio Diagnostics shares have traded in a share price range of US$ 0.19 to US$ 1.86.

Cardio Diagnostics currently has 40,439,810 shares in issue. The market capitalisation of Cardio Diagnostics is US$20.22 million. Cardio Diagnostics has a price to earnings ratio (PE ratio) of -2.37.

Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven Precision Cardiovascular Medicine company, today announced that the Company has...

Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc. (NASDAQ:...

Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, today announced it will sponsor and...

Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Preliminary CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc...

Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-powered precision cardiovascular medicine, today announced the launch of its...

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s...

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s...

Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company will...

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-driven precision cardiovascular medicine, today announced the successful...

Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests

Company to recommend pricing for its Epi+Gen CHD and PrecisionCHD tests, and pursue coverage via the Molecular Diagnostic Services (MolDx...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.1798	-27.2424242424	0.66	0.678	0.4683	2033448	0.52224476	CS
4	0.0399	9.06200317965	0.4403	0.685	0.4121	2376803	0.53639311	CS
12	0.1702	54.9032258065	0.31	1.77	0.277	6738751	0.75297775	CS
26	0.0502	11.6744186047	0.43	1.77	0.19	4490586	0.59414697	CS
52	-1.3198	-73.3222222222	1.8	1.86	0.19	2437578	0.61967257	CS
156	-3.7698	-88.7011764706	4.25	8.4999	0.171	3143074	1.58784673	CS
260	-3.7698	-88.7011764706	4.25	8.4999	0.171	3143074	1.58784673	CS

CDIO - Frequently Asked Questions (FAQ)

What is the current Cardio Diagnostics share price?

The current share price of Cardio Diagnostics is US$ 0.4802

How many Cardio Diagnostics shares are in issue?

Cardio Diagnostics has 40,439,810 shares in issue

What is the market cap of Cardio Diagnostics?

The market capitalisation of Cardio Diagnostics is USD 20.22M

What is the 1 year trading range for Cardio Diagnostics share price?

Cardio Diagnostics has traded in the range of US$ 0.19 to US$ 1.86 during the past year

What is the PE ratio of Cardio Diagnostics?

The price to earnings ratio of Cardio Diagnostics is -2.37

What is the cash to sales ratio of Cardio Diagnostics?

The cash to sales ratio of Cardio Diagnostics is 1.23k

What is the reporting currency for Cardio Diagnostics?

Cardio Diagnostics reports financial results in USD

What is the latest annual turnover for Cardio Diagnostics?

The latest annual turnover of Cardio Diagnostics is USD 17k

What is the latest annual profit for Cardio Diagnostics?

The latest annual profit of Cardio Diagnostics is USD -8.38M

What is the registered address of Cardio Diagnostics?

The registered address for Cardio Diagnostics is 8 THE GREEN, SUITE #12490, DOVER, DELAWARE, 19901

Which industry sector does Cardio Diagnostics operate in?

Cardio Diagnostics operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ONVOOrganovo Holdings Inc	US$ 1.2502 (238.81%)	386.27M
RETOReTo Eco Solutions Inc	US$ 1.065 (80.51%)	78.71M
VEROVenus Concept Inc	US$ 0.5402 (76.54%)	15.55M
SLXNSilexion Therapeutics Corporation	US$ 1.23 (64.00%)	87.74M
WAFUWah Fu Education Group Ltd	US$ 2.825 (57.82%)	125.46M
YYAIConnexa Sports Technologies Inc	US$ 0.681 (-46.38%)	6.22M
RNAZTransCode Therapeutics Inc	US$ 4.34 (-35.99%)	611.44k
ACONAclarion Inc	US$ 3.25 (-30.26%)	417.53k
BTDRBitdeer Technologies Group	US$ 9.255 (-29.35%)	16.96M
NKLANikola Corporation	US$ 0.184 (-28.35%)	37.07M
ONVOOrganovo Holdings Inc	US$ 1.2502 (238.81%)	386.27M
NVDANVIDIA Corporation	US$ 126.63 (-2.80%)	271.57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 14.41 (-16.85%)	167.52M
SMCISuper Micro Computer Inc	US$ 45.54 (-11.76%)	146.56M
TSLATesla Inc	US$ 302.80 (-8.39%)	134.25M